Breast Cancer Therapeutics Market Size and Forecasts (2020-2030)

Breast Cancer Therapeutics Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry

$3,185$5,985

Description

Breast Cancer Therapeutics Market Size and Forecast (2020–2030), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

The breast cancer therapeutics market size is expected to grow from US$ 31,073.52 million in 2022 to US$ 63,967.05 million by 2030; it is estimated to record a CAGR of 9.4% during 2022 to 2030.

Breast cancer is when the breast’s cells proliferate out of control. Breast cancer comes in several forms. Which breast cells develop into cancer determines the type of breast cancer. The ducts or lobules are where most breast cancers start. Blood and lymph vessels are two ways breast cancer can travel outside the breast. Its treatment depends on the stage of cancer. It may consist of chemotherapy, radiation, hormone therapy and surgery. The breast cancer therapeutics market growth is attributed to the growing burden of breast cancer and launch of several diagnostics and screening programs.

Personalized medicine involves tailoring treatment plans to individual patients on the basis of their genetic makeup, among other factors. This approach allows for highly targeted and effective treatments, as it considers the unique characteristics of each patient’s cancer. Advancements in genomics and molecular diagnostics have made personalized medicine a viable option in breast cancer treatment. Healthcare providers can identify specific genetic mutations or biomarkers driving the cancer’s growth by analyzing a patient’s tumor at a molecular level. This information can then be used to select the most appropriate treatment options, such as targeted therapies or immunotherapies, that are likely to be the most effective for that particular patient. The use of personalized medicine in breast cancer therapeutics has the potential to significantly improve patient outcomes. For instance, in February 2022, NIH researchers developed a personalized breast cancer therapy approach, an experimental form of immunotherapy that uses a patient’s tumor-fighting immune cells to treat those with metastatic breast cancer, advancing personalized medicine.

By providing tailored treatments to individual patients, healthcare providers can increase the likelihood of successful outcomes and reduce the risk of unnecessary side effects. In addition to improving patient outcomes, personalized medicine also offers economic benefits. By selecting treatments that are more likely to be effective, healthcare providers can reduce healthcare costs associated with ineffective treatments and avoid unnecessary expenses. As advancements in genomics and molecular diagnostics progress, personalized medicine is likely to become increasingly accessible and integrated into standard treatment protocols in the coming years. Therefore, the increasing use of personalized medicine is anticipated to bring new growth trends in the breast cancer therapeutics market.

Distribution Channel -Based Insights

Based on distribution channel, the breast cancer therapeutics market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2022. The hospital pharmacy plays a crucial role in the management of breast cancer therapeutics. They are responsible for compounding and dispensing, monitoring drug safety, medication management, educating patients, and other factors. Breast cancer is one of the most widespread cancers worldwide, and the demand for effective therapeutics is steadily increasing. Hospital pharmacies are responsible for procuring, storing, and dispensing chemotherapy medications and other treatments related to breast cancer to ensure that patients receive the right treatment in time. These pharmacies are also in authority to manage the inventory and storage of these drugs, ensuring that they are stored and handled in accordance with strict regulations. Their collaborative efforts with oncologists and healthcare teams ensure that breast cancer patients receive optimal, personalized therapeutics and comprehensive care throughout their treatment journey. Hospital pharmacies remain instrumental in delivering timely and effective breast cancer treatments, significantly impacting patients’ outcomes in battling the disease.

However, the online pharmacies segment is anticipated to register the highest CAGR during 2022–2030. Online pharmacies offer a wide array of breast cancer medications ranging from chemotherapy drugs to supportive therapies, often with home delivery services. Ensuring prescription verification and maintaining regulatory compliance, online pharmacies play a vital role in upholding the integrity of the healthcare system. They also provide convenience for patients who prefer discrete shopping or have limited mobility due to treatment. They also enable patients to compare prices and access a broader selection of breast cancer therapeutics. With services such as home delivery and patient support, online pharmacies continue to evolve, transforming the breast cancer treatment experience and breaking down geographical barriers for patients worldwide. In addition, an increasing number of patients have shifted to these pharmacies to acquire therapeutics due to their greater ease in terms of usage, which is fueling the growth of the segment.

Europe is the second leading region in the market. Breast cancer is a common type of cancer in the UK. As per the National Health Service (NHS), about one in seven women are diagnosed with breast cancer during their lifespan in Great Britain data. Each year, ~55,000 women are diagnosed with breast cancer.

Greater demand from the medical industry to treat breast cancer patients with novel therapeutics has led to greater investment in R&D, fueling the growth of the market. Companies invest in research and development to stay competitive and provide customers with cutting-edge and innovative products. In October 2021, Trodelvy, a new antibody treatment, was authorized to treat an aggressive form of cancer called ‘triple-negative breast cancer’ in the country. In November 2021, Sanofi invested US$ 180 million and entered into a new strategic collaboration with Owkin, a French-American AI start-up engaged in the discovery and development programs of four types of cancer, with a total payment of US$ 90 million. The collaboration supported Sanofi’s developing oncology portfolio in core areas such as breast cancer, lung cancer, and multiple myeloma to enhance clinical trial design and detect predictive biomarkers for diseases and treatment results.

The Italian government and national health institutes have launched several initiatives for the early detection and treatment of breast cancer. These programs include free mammograms for women aged 50–69 and a nationwide breast cancer screening program. In addition, as per the information provided by EURACTIV, the country has witnessed a strong rise in the number of specialized Breast Units, from 84 in 2012 to 173 in 2020. The country’s growing number of breast units helps healthcare professionals offer treatment to patients with breast cancer. Thus, the abovementioned factors support the market growth in the region.

The American Cancer S0ociety, World Health Organization (WHO), National Institutes of Health, and US FDA are among the primary and secondary sources referred to while preparing the breast cancer therapeutics market report.

Summary Info

Industry:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Targeted Drug Therapy Segment, by Drug Therapy, to Dominate Breast Cancer Therapeutics Market During 2022–2030

According to our new research study on “Breast Cancer Therapeutics Market Size and Forecast (2020–2030), Global and Regional Share, Trends, and Growth Opportunity Analysis,” the breast cancer therapeutics market size is expected to grow from US$ 31.073.52 billion in 2022 and to reach a value of US$ 63.967 billion by 2030; it is anticipated to record a CAGR of 9.4% from 2022 to 2030. Key factors driving the market growth are growing burden of breast cancer and launch of several diagnostics and screening programs. However, high cost of diagnosis and treatments hinders the breast cancer therapeutics market growth.

Governments of various countries across the globe recognize the importance of addressing breast cancer and are implementing policies to improve access to effective treatments. Many governments and private organizations have increased funding for research and development in breast cancer therapeutics, resulting in the development of innovative drugs and therapies. For instance, Susan G. Komen, the leading breast cancer charity in the world, recently announced the awarding of 49 new grants to scientists at 28 prestigious US universities. The US$ 19.3 million in new grants continue Komen’s dedication to assisting the next generation of diverse leaders in breast cancer research while supporting two areas of focus—advancing precision medicine and eradicating disparities in breast cancer outcomes. This increased investment in research has allowed pharmaceutical companies to explore new treatment options and develop highly targeted and effective therapies for breast cancer patients.

Several government bodies across the world are also taking steps to improve access to these treatments by implementing reimbursement policies and healthcare initiatives that cover the cost of breast cancer therapeutics for patients. This means that more patients can afford these treatments and have access to the latest advancements in breast cancer therapeutics. The increased government support has also created a favorable market environment for healthcare providers. With more funding and resources available, healthcare providers are able to offer their patients a wider range of treatment options. This improves patient outcomes and allows healthcare providers to stay competitive in the market. Overall, the increased support from governments and private organizations for breast cancer therapeutics has driven innovation, leading to new and improved treatments. It has also improved access to these treatments, benefiting more patients. This presents a significant opportunity for the breast cancer therapeutics market growth as pharmaceutical companies and healthcare providers continue to invest in research and development activities and expand their offerings to meet the growing demand.

Eli Lilly and Co, Novartis AG, AstraZeneca Plc, Pfizer Inc, Gilead Sciences Inc, Merck & Co Inc, Genentech Inc., Teva Pharmaceutical Industries Ltd, and Amgen Inc. are among the key companies operating in the breast cancer therapeutics market. The companies have been implementing various strategies that contribute to their growth and lead to various changes in the market. The companies have utilized both organic strategies (such as launches, expansion, and product approvals) and inorganic strategies (such as product launches, partnerships, and collaborations).

For instance, in June 2023, Gilead Sciences, Inc. adopted a positive opinion for Trodelvy (sacituzumab govitecan) from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) as monotherapy to treat patients with unresectable or metastatic hormone receptor (HR)-positive and HER2-negative breast cancer patients who have received endocrine-based therapy and at least two additional systemic therapies in the advanced setting.

Breast Cancer Therapeutics Market , by Geography, 2022 (%)

Source: the research team Analysis

The report segments the breast cancer therapeutics market as follows:

The breast cancer therapeutics market, by drug therapy, is segmented into targeted drug therapy, hormonal drug therapy, chemotherapy, and immunotherapy/ biological therapy. The breast cancer therapeutics market, by breast cancer type, is segmented into hormone receptor, HER2+, and triple-negative breast cancer. The breast cancer therapeutics market, by distribution channel, is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. Based on geography, the breast cancer therapeutics market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). 

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the breast cancer therapeutics market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Breast Cancer Therapeutics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Breast Cancer Therapeutics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Growing Burden of Breast Cancer
5.1.2 Launch of Several Diagnostics and Screening Programs
5.2 Key Market Restraints
5.2.1 High Cost of Diagnosis and Treatment
5.3 Key Market Opportunities
5.3.1 Increased Support from Government and Private Organizations
5.4 Key Future Trends
5.4.1 Increasing Use of Personalized Medicine
5.5 Impact Analysis:
6. Breast Cancer Therapeutics Market – Global Market Analysis
6.1 Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 2030
7. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Drug Therapy
7.1 Overview
7.2 Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
7.3 Targeted Drug Therapy
7.3.1 Overview
7.3.2 Targeted Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Global Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020 €“2030 (US$ Million)
7.4 Hormonal Drug Therapy
7.4.1 Overview
7.4.2 Hormonal Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Chemotherapy
7.5.1 Overview
7.5.2 Chemotherapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Immunotherapy/ Biological Therapy
7.6.1 Overview
7.6.2 Immunotherapy/ Biological Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Breast Cancer Type
8.1 Overview
8.2 Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
8.3 Hormone Receptor
8.3.1 Overview
8.3.2 Hormone Receptor: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8.4 HER2+ (human epidermal growth factor receptor 2)
8.4.1 Overview
8.4.2 HER2+: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Triple-Negative Breast Cancer
8.5.1 Overview
8.5.2 Triple-Negative Breast Cancer: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Distribution Channel
9.1 Overview
9.2 Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Drug Store and Retail Pharmacies
9.4.1 Overview
9.4.2 Drug Store and Retail Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
10. Breast Cancer Therapeutics Market – Geographical Analysis
10.1 North America Breast Cancer Therapeutics Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.3.1 North America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.3.2 North America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.4 North America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.1.5 North America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.1.6 North America Breast Cancer Therapeutics Market, by Country
10.1.6.1 US
10.1.6.1.1 US Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.1.2 US: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.1.2.1 US: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.1.2.2 US: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.1.3 US: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.1.6.1.4 US: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.1.6.2 Canada
10.1.6.2.1 Canada Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.2.2 Canada: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.2.2.1 Canada: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.2.2.2 Canada: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.2.3 Canada: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.1.6.2.4 Canada: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.1.6.3 Mexico
10.1.6.3.1 Mexico Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.3.2 Mexico: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.3.2.1 Mexico: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.3.2.2 Mexico: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.1.6.3.3 Mexico: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.1.6.3.4 Mexico: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.2 Europe Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.3.1 Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.3.2 Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.4 Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.2.5 Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.2.6 Europe Breast Cancer Therapeutics Market, by Country
10.2.6.1 UK
10.2.6.1.1 UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.2 UK: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.1.2.1 UK: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.1.2.2 UK: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.1.3 UK: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.2.6.1.4 UK: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.2.6.2 Germany
10.2.6.2.1 Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.2 Germany: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.2.2.1 Germany: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.2.2.2 Germany: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.2.3 Germany: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.2.6.2.4 Germany: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.2.6.3 France
10.2.6.3.1 France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.2 France: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.3.2.1 France: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.3.2.2 France: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.3.3 France: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.2.6.3.4 France: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.2.6.4 Italy
10.2.6.4.1 Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.2 Italy: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.4.2.1 Italy: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.4.2.2 Italy: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.4.3 Italy: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.2.6.4.4 Italy: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.2.6.5 Spain
10.2.6.5.1 Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.2 Spain: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.5.2.1 Spain: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.5.2.2 Spain: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.5.3 Spain: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.2.6.5.4 Spain: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.2.6.6 Rest of Europe
10.2.6.6.1 Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.2 Rest of Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.6.2.1 Rest of Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.6.2.2 Rest of Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.2.6.6.3 Rest of Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.3 Asia Pacific Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.3.1 Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.3.2 Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.4 Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.3.5 Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.3.6 Asia Pacific Breast Cancer Therapeutics Market, by Country
10.3.6.1 China
10.3.6.1.1 China Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.2 China: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.1.2.1 China: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.1.2.2 China: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.1.3 China: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.3.6.1.4 China: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.3.6.2 Japan
10.3.6.2.1 Japan Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.2 Japan: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.2.2.1 Japan: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.2.2.2 Japan: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.2.3 Japan: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.3.6.2.4 Japan: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.3.6.3 India
10.3.6.3.1 India Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.2 India: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.3.2.1 India: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.3.2.2 India: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.3.3 India: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.3.6.3.4 India: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.3.6.4 Australia
10.3.6.4.1 Australia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.2 Australia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.4.2.1 Australia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.4.2.2 Australia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.4.3 Australia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.3.6.4.4 Australia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.3.6.5 South Korea
10.3.6.5.1 South Korea Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.2 South Korea: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.5.2.1 South Korea: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.5.2.2 South Korea: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.5.3 South Korea: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.3.6.5.4 South Korea: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific
10.3.6.6.1 Rest of Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.6.2.1 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.6.2.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.4 Middle East & Africa Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.3.1 Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.3.2 Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.4 Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.4.5 Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.4.6 Middle East & Africa Breast Cancer Therapeutics Market, by Country
10.4.6.1 Saudi Arabia
10.4.6.1.1 Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.1.2 Saudi Arabia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.1.2.1 Saudi Arabia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.1.2.2 Saudi Arabia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.1.3 Saudi Arabia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.4.6.1.4 Saudi Arabia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.4.6.2 UAE
10.4.6.2.1 UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.2.2 UAE: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.2.2.1 UAE: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.2.2.2 UAE: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.2.3 UAE: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.4.6.2.4 UAE: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.4.6.3 South Africa
10.4.6.3.1 South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.3.2 South Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.3.2.1 South Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.3.2.2 South Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.3.3 South Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.4.6.3.4 South Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.4.6.4 Rest of Middle East & Africa
10.4.6.4.1 Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.4.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.4.2.1 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.4.2.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.5 South & Central America Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.3.1 South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.3.2 South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.4 South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.5.5 South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.5.6 South & Central America Breast Cancer Therapeutics Market, by Country
10.5.6.1 Brazil
10.5.6.1.1 Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.2 Brazil: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.1.2.1 Brazil: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.1.2.2 Brazil: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.1.3 Brazil: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.5.6.1.4 Brazil: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.2 Argentina: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.2.2.1 Argentina: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.2.2.2 Argentina: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.2.3 Argentina: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.5.6.2.4 Argentina: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.2 Rest of South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.3.2.1 Rest of South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.3.2.2 Rest of South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 €“2030 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 €“2030 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 €“2030 (US$ Million)
11. Breast Cancer Therapeutics Market €“Industry Landscape
11.1 Overview
11.2 Growth Strategies in Breast Cancer Therapeutics Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Eli Lilly and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Eisai Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novartis AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AstraZeneca Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Gilead Sciences Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck & Co Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Genentech Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amgen Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Breast Cancer Therapeutics Market Segmentation
Table 2. Global Breast Cancer Therapeutics Market, by Targeted Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 3. Global Breast Cancer Therapeutics Market, by Hormonal Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 8. North America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 9. US Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 10. US Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 11. US Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 12. US Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 13. US Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 19. Mexico Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 24. Europe Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 25. Europe Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 29. UK Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 30. UK Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 31. UK Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 32. UK Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 33. UK Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 34. Germany Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 35. Germany Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 36. Germany Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 37. Germany Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 38. Germany Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 39. France Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 40. France Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 41. France Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 42. France Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 43. France Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 44. Italy Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 45. Italy Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 46. Italy Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 47. Italy Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 48. Italy Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 49. Spain Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 50. Spain Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 51. Spain Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 52. Spain Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 53. Spain Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Europe Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Europe Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 56. Rest of Europe Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 57. Rest of Europe Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 58. Rest of Europe Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 59. Asia Pacific Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 60. Asia Pacific Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 61. Asia Pacific Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 62. Asia Pacific Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 63. Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 64. China Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 65. China Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 66. China Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 67. China Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 68. China Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 69. Japan Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 70. Japan Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 71. Japan Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 72. Japan Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 73. Japan Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 74. India Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 75. India Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 76. India Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 77. India Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 78. India Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 79. Australia Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 80. Australia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 81. Australia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 82. Australia Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 83. Australia Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 84. South Korea Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 85. South Korea Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 86. South Korea Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 87. South Korea Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 88. South Korea Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 89. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Asia Pacific Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Asia Pacific Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 93. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 94. Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 95. Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 96. Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 97. Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 98. Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 99. Saudi Arabia Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 100. Saudi Arabia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 101. Saudi Arabia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 102. Saudi Arabia Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 103. Saudi Arabia Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 104. UAE Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 105. UAE Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 106. UAE Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 107. UAE Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 108. UAE Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 109. South Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 110. South Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 111. South Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 112. South Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 113. South Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 114. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 115. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 116. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 117. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 118. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 119. South & Central America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 120. South & Central America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 121. South & Central America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 122. South & Central America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 123. South & Central America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 124. Brazil Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 125. Brazil Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 126. Brazil Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 127. Brazil Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 128. Brazil Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 129. Argentina Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 130. Argentina Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 131. Argentina Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 132. Argentina Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 133. Argentina Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of South & Central America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of South & Central America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of South & Central America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of South & Central America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of South & Central America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
Table 139. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market
Table 140. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
Table 141. Glossary of Terms, Breast Cancer Therapeutics Market

LIST OF FIGURES

Figure 1. Breast Cancer Therapeutics Market Segmentation, By Geography
Figure 2. Global – PEST Analysis
Figure 3. Breast Cancer Therapeutics Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 2030
Figure 6. Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
Figure 7. Targeted Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 8. Hormonal Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 9. Chemotherapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immunotherapy/ Biological Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 11. Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
Figure 12. Hormone Receptor: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. HER2+: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. Triple-Negative Breast Cancer: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
Figure 16. Hospital Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Drug Store and Retail Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Online Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America: Breast Cancer Therapeutics Market, by Key Country Revenue (2022) (US$ Million)
Figure 20. North America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. North America Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 22. US Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Canada Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Mexico Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Europe Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
Figure 26. Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Europe Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 28. UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Asia Pacific Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
Figure 35. Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Asia Pacific Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 37. China Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Japan Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. India Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Australia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. South Korea Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Rest of Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Middle East & Africa Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
Figure 44. Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Middle East & Africa Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 46. Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 49. Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. South & Central America Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
Figure 51. South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. South & Central America Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 53. Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Growth Strategies in Breast Cancer Therapeutics Market

The List of Companies – Breast Cancer Therapeutics Market 
o Eli Lilly and Co,
o Eisai Co Ltd
o Novartis AG
o AstraZeneca Plc
o Pfizer Inc
o Gilead Sciences Inc
o Merck & Co Inc
o Genentech Inc
o Teva Pharmaceutical Industries Ltd
o Amgen Inc

Reviews

There are no reviews yet.

Be the first to review “Breast Cancer Therapeutics Market Size and Forecasts (2020-2030)”